Literature DB >> 8598795

Pneumocystis carinii infection in patients with chronic bronchial disease.

E J Calderón, C Regordan, F J Medrano, M Ollero, J M Varela.   

Abstract

Entities:  

Mesh:

Year:  1996        PMID: 8598795     DOI: 10.1016/s0140-6736(96)91468-3

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  33 in total

Review 1.  Current understanding of Pneumocystis immunology.

Authors:  Michelle N Kelly; Judd E Shellito
Journal:  Future Microbiol       Date:  2010-01       Impact factor: 3.165

2.  Development and evaluation of a quantitative, touch-down, real-time PCR assay for diagnosing Pneumocystis carinii pneumonia.

Authors:  Hans Henrik Larsen; Henry Masur; Joseph A Kovacs; Vee J Gill; Victoria A Silcott; Palaniandy Kogulan; Janine Maenza; Margo Smith; Daniel R Lucey; Steven H Fischer
Journal:  J Clin Microbiol       Date:  2002-02       Impact factor: 5.948

3.  Evaluation of diagnostic value and epidemiological implications of PCR for Pneumocystis carinii in different immunosuppressed and immunocompetent patient groups.

Authors:  A Sing; K Trebesius; A Roggenkamp; H Rüssmann; K Tybus; F Pfaff; J R Bogner; C Emminger; J Heesemann
Journal:  J Clin Microbiol       Date:  2000-04       Impact factor: 5.948

4.  Pneumocystis carinii f. sp. hominis DNA in immunocompetent health care workers in contact with patients with P. carinii pneumonia.

Authors:  R F Miller; H E Ambrose; A E Wakefield
Journal:  J Clin Microbiol       Date:  2001-11       Impact factor: 5.948

5.  Population structure of rat-derived Pneumocystis carinii in Danish wild rats.

Authors:  R J Palmer; O P Settnes; J Lodal; A E Wakefield
Journal:  Appl Environ Microbiol       Date:  2000-11       Impact factor: 4.792

6.  Pneumocystis jirovecii colonization is associated with enhanced Th1 inflammatory gene expression in lungs of humans with chronic obstructive pulmonary disease.

Authors:  Meghan E Fitzpatrick; John R Tedrow; Maria E Hillenbrand; Lorrie Lucht; Thomas Richards; Karen A Norris; Yingze Zhang; Frank C Sciurba; Naftali Kaminski; Alison Morris
Journal:  Microbiol Immunol       Date:  2014-03       Impact factor: 1.955

7.  Asymptomatic carriage of Pneumocystis jiroveci in subjects undergoing bronchoscopy: a prospective study.

Authors:  N A Maskell; D J Waine; A Lindley; J C T Pepperell; A E Wakefield; R F Miller; R J O Davies
Journal:  Thorax       Date:  2003-07       Impact factor: 9.139

8.  Pneumocystis jiroveci isolates with dihydropteroate synthase mutations in patients with chronic bronchitis.

Authors:  E Calderón; C de la Horra; F J Medrano; A López-Suárez; M A Montes-Cano; N Respaldiza; J Elvira-González; J Martín-Juan; A Bascuñana; J M Varela
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2004-06-03       Impact factor: 3.267

9.  Serum markers in interstitial pneumonia with and without Pneumocystis jirovecii colonization: a prospective study.

Authors:  Yasuo Shimizu; Noriaki Sunaga; Kunio Dobashi; Makoto Fueki; Naoto Fueki; Sohei Makino; Masatomo Mori
Journal:  BMC Infect Dis       Date:  2009-04-22       Impact factor: 3.090

10.  Risk for Pneumocystis carinii transmission among patients with pneumonia: a molecular epidemiology study.

Authors:  Elodie Senggen Manoloff; Patrick Francioli; Patrick Taffé; Guy Van Melle; Jacques Bille; Philippe M Hauser
Journal:  Emerg Infect Dis       Date:  2003-01       Impact factor: 6.883

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.